Medicare Compliance & Reimbursement

Pharmaceuticals:

NO RELIEF ON AWP SCRUTINY

Pharmaceutical companies across the country are coming increasingly under the gun as state attorneys general nationwide take them to task for allegedly ripping of Medicaid and Medicare by manipulating reported drug prices. In the latest move, Connecticut AG Richard Blumenthal says he plans to sue seven drugmakers for illegally playing fast and loose with the “average wholesale price,” a figure [...]
You’ve reached your limit of free articles. Already a subscriber? Log in.
Not a subscriber? Subscribe today to continue reading this article. Plus, you’ll get:
  • Simple explanations of current healthcare regulations and payer programs
  • Real-world reporting scenarios solved by our expert coders
  • Industry news, such as MAC and RAC activities, the OIG Work Plan, and CERT reports
  • Instant access to every article ever published in Revenue Cycle Insider
  • 6 annual AAPC-approved CEUs
  • The latest updates for CPT®, ICD-10-CM, HCPCS Level II, NCCI edits, modifiers, compliance, technology, practice management, and more

Other Articles in this issue of

Medicare Compliance & Reimbursement

View All